Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Endocrinological Investigation
|
July 2, 2017
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors
M Del Prete, A Di Sarno, R Modica, et al.
Journal of Clinical Pathology
|
December 25, 2003
Analysis of cell cycle regulator proteins in non-small cell lung cancer
V Esposito, A Baldi, G Tonini, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
G Di Lorenzo, R Autorino, G Bruni, et al.
European Review for Medical and Pharmacological Sciences
|
December 2, 2022
Management of systemic prostate cancer: current algorithm from castration sensitive to castration resistant setting
C D'Aniello, C Cavaliere, C Foglia, et al.
European Review for Medical and Pharmacological Sciences
|
December 18, 2020
Penile cancer: prognostic and predictive factors in clinical decision-making
C D'Aniello, C Cavaliere, B A Facchini, et al.
Acta Psychiatrica Scandinavica
|
July 9, 2002
Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study
F Starace, L Bartoli, M S Aloisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2014
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial
F Ciardiello, N Normanno, E Maiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
F Ciardiello, N Normanno, E Martinelli, et al.
ESMO Open
|
December 5, 2023
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients
L Arenare, C Porta, D Barberio, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Endocrinological Investigation
|
July 2, 2017
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors
M Del Prete, A Di Sarno, R Modica, et al.
Journal of Clinical Pathology
|
December 25, 2003
Analysis of cell cycle regulator proteins in non-small cell lung cancer
V Esposito, A Baldi, G Tonini, et al.
Oncology Reports
|
May 25, 2011
Cardiovascular monitoring of drug-resistant lymphoma patients treated with epoch chemotherapy plus high-dose verapamil in continuous-infusion
P Tagliaferri, P Correale, M Mottola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
G Di Lorenzo, R Autorino, G Bruni, et al.
European Review for Medical and Pharmacological Sciences
|
December 2, 2022
Management of systemic prostate cancer: current algorithm from castration sensitive to castration resistant setting
C D'Aniello, C Cavaliere, C Foglia, et al.
European Review for Medical and Pharmacological Sciences
|
December 18, 2020
Penile cancer: prognostic and predictive factors in clinical decision-making
C D'Aniello, C Cavaliere, B A Facchini, et al.
Acta Psychiatrica Scandinavica
|
July 9, 2002
Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study
F Starace, L Bartoli, M S Aloisi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2014
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial
F Ciardiello, N Normanno, E Maiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
F Ciardiello, N Normanno, E Martinelli, et al.
ESMO Open
|
December 5, 2023
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients
L Arenare, C Porta, D Barberio, et al.
Page
of 3